✦ LIBER ✦

Aromatase inhibitors versus tamoxifen for management of postmenopausal breast cancer in the advanced disease and neoadjuvant settings

✍ Scribed by James N Ingle; Vera J Suman

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New aromatase inhibitors for the treatme

✍ P.Chr. de Jong; G.H. Blijham 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Letrozole versus tamoxifen in the treatm

✍ Ian E Smith 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 54 KB

S62– Cost-effectiveness of aromatase inh

✍ Oscar Andrés Gamboa Garay; Sandra Díaz; Oscar Garcia; Fernando Perry; Mario Garc 📂 Article 📅 2010 🏛 SAGE Publications 🌐 English ⚖ 48 KB

Randomized trial or the selective aromat

✍ R. Peréz-Carrion; V. Alberola; F. Calabresi; R-Th. Michel; R. Santos; M. Fehling 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 298 KB

Anastrozole versus tamoxifen as neoadjuv

✍ I Smith; L Cataliotti 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 331 KB

2092 POSTER Comparison of cost-effective

✍ K. El Ouagari; J. Karnon; S. Kaura 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 77 KB